Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2
暂无分享,去创建一个
J. Steitz | S. Takyar | V. Fok | G. Pimienta | M. Haslip | Maria Nagy
[1] Gary D Bader,et al. A draft map of the human proteome , 2014, Nature.
[2] J. Wilusz,et al. Cytoplasmic Viruses: Rage against the (Cellular RNA Decay) Machine , 2013, PLoS pathogens.
[3] N. Chiorazzi,et al. B cell receptor signaling in chronic lymphocytic leukemia. , 2013, Trends in immunology.
[4] M. Garcia-Blanco,et al. Epstein-Barr Virus Induces Global Changes in Cellular mRNA Isoform Usage That Are Important for the Maintenance of Latency , 2013, Journal of Virology.
[5] H. Prats,et al. VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level , 2013, Nucleic acids research.
[6] J. Steitz,et al. AUF1/hnRNP D is a novel protein partner of the EBER1 noncoding RNA of Epstein-Barr virus. , 2012, RNA.
[7] R. Hassan,et al. Relationship of Epstein-Barr Virus and Interleukin 10 Promoter Polymorphisms with the Risk and Clinical Outcome of Childhood Burkitt Lymphoma , 2012, PloS one.
[8] J. Mertz,et al. Shutoff of BZLF1 Gene Expression Is Necessary for Immortalization of Primary B Cells by Epstein-Barr Virus , 2012, Journal of Virology.
[9] R. Robey,et al. AUF1/hnRNP D represses expression of VEGF in macrophages , 2012, Molecular biology of the cell.
[10] Jin Billy Li,et al. Accurate identification of human Alu and non-Alu RNA editing sites , 2012, Nature Methods.
[11] David R. Kelley,et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.
[12] M. Rapé,et al. Regulation of ubiquitin chain initiation to control the timing of substrate degradation. , 2011, Molecular cell.
[13] Cole Trapnell,et al. Computational methods for transcriptome annotation and quantification using RNA-seq , 2011, Nature Methods.
[14] M. Selbach,et al. Global quantification of mammalian gene expression control , 2011, Nature.
[15] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[16] M. Mann,et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.
[17] Robert E. White,et al. Cellular Gene Expression That Correlates with EBER Expression in Epstein-Barr Virus-Infected Lymphoblastoid Cell Lines , 2011, Journal of Virology.
[18] S. Pestka,et al. RNA-Binding Protein AUF1 Regulates Lipopolysaccharide-Induced IL10 Expression by Activating IκB Kinase Complex in Monocytes , 2010, Molecular and Cellular Biology.
[19] P. Moore,et al. Why do viruses cause cancer? Highlights of the first century of human tumour virology , 2010, Nature Reviews Cancer.
[20] D. Ganem,et al. Viral latency and its regulation: lessons from the gamma-herpesviruses. , 2010, Cell host & microbe.
[21] S. Ishikawa,et al. Downregulation of microRNA-200 in EBV-associated gastric carcinoma. , 2010, Cancer research.
[22] M. Jantsch,et al. Proteome diversification by adenosine to inosine RNA-editing , 2010, RNA biology.
[23] K. Takada,et al. Modulation of innate immunity system by Epstein–Barr virus‐encoded non‐coding RNA and oncogenesis , 2010, Cancer science.
[24] M. Gerstein,et al. EBNA1 regulates cellular gene expression by binding cellular promoters , 2009, Proceedings of the National Academy of Sciences.
[25] I. K. Ruf,et al. Growth-Promoting Properties of Epstein-Barr Virus EBER-1 RNA Correlate with Ribosomal Protein L22 Binding , 2009, Journal of Virology.
[26] D. Thorley-Lawson,et al. The curious case of the tumour virus: 50 years of Burkitt's lymphoma , 2008, Nature Reviews Microbiology.
[27] Sun-Mi Park,et al. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.
[28] Anason S. Halees,et al. ARED Organism: expansion of ARED reveals AU-rich element cluster variations between human and mouse , 2007, Nucleic Acids Res..
[29] T. Kanda,et al. Epstein-Barr Virus (EBV)-Encoded RNA 2 (EBER2) but Not EBER1 Plays a Critical Role in EBV-Induced B-Cell Growth Transformation , 2007, Journal of Virology.
[30] R. Davis. Fc receptor-like molecules. , 2007, Annual review of immunology.
[31] J. Steitz,et al. Epstein-Barr virus noncoding RNAs are confined to the nucleus, whereas their partner, the human La protein, undergoes nucleocytoplasmic shuttling , 2006, The Journal of cell biology.
[32] J. Steitz,et al. Multiple domains of EBER 1, an Epstein-Barr virus noncoding RNA, recruit human ribosomal protein L22. , 2006, RNA.
[33] B. Graveley. Coordinated control of splicing and translation , 2005, Nature Structural &Molecular Biology.
[34] D. Stevenson,et al. Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9. , 2005, Cancer research.
[35] M. Colonna,et al. A new Fc receptor homolog, FREB2, found in germinal center B cells , 2005, Genes and Immunity.
[36] T. Kanda,et al. Critical Role of Epstein-Barr Virus (EBV)-Encoded RNA in Efficient EBV-Induced B-Lymphocyte Growth Transformation , 2005, Journal of Virology.
[37] L. Young,et al. Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.
[38] M. Hentze,et al. Molecular mechanisms of translational control , 2004, Nature Reviews Molecular Cell Biology.
[39] B. Damania. Oncogenic γ-herpesviruses: comparison of viral proteins involved in tumorigenesis , 2004, Nature Reviews Microbiology.
[40] E. Birney,et al. The International Protein Index: An integrated database for proteomics experiments , 2004, Proteomics.
[41] D. Fremont,et al. An unusual Fc receptor-related protein expressed in human centroblasts , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[42] T. Naoe,et al. Epstein–Barr virus‐encoded poly(A)− RNA supports Burkitt's lymphoma growth through interleukin‐10 induction , 2000, The EMBO journal.
[43] T. Kurosaki,et al. BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. , 2000, Immunity.
[44] Y. Iwanaga,et al. Malignant transformation of B lymphoma cell line BJAB by Epstein–Barr virus‐encoded small RNAs , 2000, FEBS letters.
[45] J. Sample,et al. Epstein-Barr Virus Small RNAs Potentiate Tumorigenicity of Burkitt Lymphoma Cells Independently of an Effect on Apoptosis , 2000, Journal of Virology.
[46] E. Kieff,et al. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors , 1993, Journal of virology.
[47] E. Kieff,et al. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[48] M. Shu,et al. Epstein-Barr virus small RNA (EBER) genes: Unique transcription units that combine RNA polymerase II and III promoter elements , 1989, Cell.
[49] J. Steitz,et al. Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells , 1988, Journal of virology.
[50] J. Steitz,et al. Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII , 1981, Molecular and cellular biology.
[51] J. Steitz,et al. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[52] Ruedi Aebersold,et al. Comprehensive proteomics. , 2011, Current opinion in biotechnology.
[53] K. Takada,et al. Role of EBERs in the pathogenesis of EBV infection. , 2010, Advances in cancer research.
[54] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[55] B. Damania. Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis. , 2004, Nature reviews. Microbiology.
[56] B. Alabyev,et al. FCRL, a novel member of the leukocyte Fc receptor family possesses unique structural features. , 2002, European journal of immunology.